Multiple Myeloma: New Evidence and Insights from the Immunoglobulin Heavy Chain Gene and Phenotypes

References

• Greipp P. R., Kyle R. A. Clinical, morphological and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. Blood 1983; 62: 166–71
   PubMed Web of Science ®Google Scholar
• Boccadoro M., Durie B. G. M., Frutiger Y., Gavarotti P., Redoglia V., Massaia M., D'Alberto M., Marmont F., Gallamini A., Tribalto M., Pileri A. Lack of correlation between plasma cell labeling index and serum beta-2-microglobulin in monoclonal gammopathies. Acta Haemtol. 1987; 78: 239–42
   PubMed Web of Science ®Google Scholar
• Buchsbaum R. J., Schwartz R. S. Cellular origins of hematologic neoplasms. N. Eng. J. Med. 1990; 322: 694–6
   PubMed Web of Science ®Google Scholar
• Bakkus M. H. C., Heirman C., Van Riet I., Van Camp B., Thielemans K. Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood 1992; 80: 2326–35
   PubMed Web of Science ®Google Scholar
• Billadeau D., Ahlmann G., Greipp P., Van Ness B. The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J. Exp. Med. 1993; 178: 1023–31
   PubMed Web of Science ®Google Scholar
• Corrandini P., Boccadoro M., Voena C., Pileri A. Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to Cμ sequence in immunoglobulin (IgG-) and IgA-secreting multiple myelomas. J. Exp. Med. 1993; 178: 1091–6
   PubMed Web of Science ®Google Scholar
• Bakkus M. H. C., Van Riet I., Van Camp B., Thielemans K. Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell. Br. J. Haematol. 1994; 87: 68–74
   PubMed Web of Science ®Google Scholar
• Takishita M., Kosaka M., Goto T., Saito S. Cellular origin and extent of clonal involvement in multiple myeloma: genetic and phenotypic studies. Br. J. Haematol. 1994; 87: 735–42
   PubMed Web of Science ®Google Scholar
• Stewart A. K., Schwartz R. S. Immunoglobulin V region and B cell. Blood 1994; 83: 1717–30
   PubMed Web of Science ®Google Scholar
• Schatz D. G., Oettinger M. A., Schlissel M. S. V(D)J recombination: molecular biology and regulation. Annu. Rev. Immunol. 1992; 10: 359–83
   PubMed Web of Science ®Google Scholar
• Kleinfield R., Hardy R. R., Tarlinton D., Dangl J., Herzenberg L. A., Weigert M. Recombination between an expressed immunoglobulin heavy-chain gene and a germline variable gene segment in a Ly 1 + B-cell lymphoma. Nature 1986; 322: 843–6
   PubMed Web of Science ®Google Scholar
• Berek C., Milstein C. Mutation drift and repertoire shift in the maturation of the immune response. Immunol. Rev. 1987; 96: 23–41
   PubMed Web of Science ®Google Scholar
• MacLennan I. C. M. Germinal centers. Annu. Rev. Immunol. 1994; 12: 117–39
   PubMed Web of Science ®Google Scholar
• Berek C., Berger A., Apel M. Mutation of the immune response in germinal centers. Cell 1991; 67: 1121–9
   PubMed Web of Science ®Google Scholar
• Gray D. Immunological memory. Annu. Rev. Immunol. 1993; 11: 49–77
   PubMed Web of Science ®Google Scholar
• Harriman W., Volk H., Defranoux N., Wabl M. immunoglobulin class switch recombination. Annu. Rev. Immunol. 1993; 11: 361–84
   PubMed Web of Science ®Google Scholar
• Bird J., Galili N., Link M., Stites D., Sklar J. Continuing rearrangement but absence of somatic hypermutation in immunoglobulin genes of human B cell precursor leukemia. J. Exp. Med. 1988; 168: 229–45
   PubMed Web of Science ®Google Scholar
• Wasserman R., Yamada M., Ito Y., Finger L. R., Reichard B. A., Shane S., Lange B., Rovera G. VH gene rearrangement events can modify the immunoglobulin heavy chain during progression of B-lineage acute lymphoblastic leukemia. Blood 1992; 79: 223–8
   PubMed Web of Science ®Google Scholar
• Bahler D. W., Levy R. Clonal evolution of a follicular lymphoma: evidence for antigen selection. Proc. Natl. Acad. Sci. USA 1992; 89: 6770–4
   PubMed Web of Science ®Google Scholar
• Carroll W. L., Yu M., Link M. P., Korsmeyer S. J. Absence of Ig V region gene somatic hypermutation in advanced Burkitt's lymphoma. J. Immunol. 1989; 143: 692–8
   PubMed Web of Science ®Google Scholar
• Pratt L. F., Rassenti L., Lanick J., Robbins B., Banks P. M., Kipps T. J. Ig V region gene expression in small lymphocytic lymphoma with little or no somatic hypermutation. J. Immunol. 1989; 143: 699–705
   PubMed Web of Science ®Google Scholar
• Hummel M., Tamaru J., Kalvelage B., Stein H. Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood 1994; 84: 403–7
   PubMed Web of Science ®Google Scholar
• Aoki H., Takishita M., Kosaka M., Saito S. Frequent somatic mutations in D and/or JH segments of Ig gene in Waldenström's macroglobulinemia and chronic lymphocytic leukemia (CLL) with Richter's syndrome, but not in common CLL. Blood 1995, in press
   Web of Science ®Google Scholar
• Wagner S. D., Martinelli V., Luzzatto L. Similar patterns of VK gene usage but not different degrees of somatic mutation in hairy cell leukemia, prolymphocytic leukemia, Waldenstrom's macroglobulinemia, and myeloma. Blood 1994; 83: 3647–53
   PubMed Web of Science ®Google Scholar
• Yamada M., Wasserman R., Lange B., Reichard B. A., Womer R. B., Rovera G. Minimal residual disease in childhood B-lineage lymphoblastic leukemia: persistence of leukemic cells during the first 18 months of treatment. N. Engl. J. Med. 1990; 323: 448–55
   PubMed Web of Science ®Google Scholar
• Kiyokawa N., Kokai Y., Ishimoto K., Fujita H., Fujimoto J., Hata J. Characterization of the common ALL antigen (CD10) as an activation molecule on mature human B cells. Clin. Exp. Immunol. 1990; 79: 322–7
   PubMed Web of Science ®Google Scholar
• Baum C. M., Weismann I. L., Tsukamoto A. S., Buckle A. M., Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proc. Natl. Acad. Sci. USA 1992; 89: 2804–8
   PubMed Web of Science ®Google Scholar
• Barlogie B., Epstein J., Selvanayagam P., Alexanian R. Plasma cell myeloma—New biological insights and advances in therapy. Blond 1989; 73: 865–79
   PubMed Web of Science ®Google Scholar
• Epstein J., Xiao H., He X-Y. Markers of multiple hematopoietic-cell lineages in multiple myeloma. N. Eng. J. Med. 1990; 322: 664–8
   PubMed Web of Science ®Google Scholar
• Tarstappen L. W. M.M., Johnsen S., Segers-Nolten I. M. J., Loken M. Identification and characterization of plasma cells in normal human hone marrow by high resolution flow cytometry. Blood 1990; 76: 1739–47
   PubMed Web of Science ®Google Scholar
• Fruehauf S., Haas R., Zeller W. J., Hunstein W. CD34 selection for purging in multiple myeloma and analysis of CD34+ B cell precursors. Stem Cells 1994; 12: 95–102
   PubMed Web of Science ®Google Scholar
• Fearon E. R., Vogelstein B. A genetic model for col-orectal tumorigenesis. Cell 1990; 61: 759–67
   PubMed Web of Science ®Google Scholar
• Shpilberg O., Modan M., Modan B., Chetrit A., Fuchs Z., Ramot B. Familial aggregation of haematological neoplasms: a controlled study. Br. J. Haematol. 1994; 87: 75–80
   PubMed Web of Science ®Google Scholar
• Taniwaki M., Nishida K., Takashima T., Nakagawa H., Fujii H., Tamaki T., Shimazaki C., Horiike S., Misawa S., Abe T., Kashima K. Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia. Blood 1994; 84: 2283–90
   PubMed Web of Science ®Google Scholar
• Corradini P., Inghirami G., Astolfi M., Ladetto M., Voena C., Ballerini P., Gu W., Nilsson K., Knowles D. M., Boccadoro M., Pileri A., Dalla-Favera R. Inactivation of tumor sup-presser genes, p53 and Rb1, in plasma cell dyscrasias. Leukemia 1994; 8: 758–67
   PubMed Web of Science ®Google Scholar
• Neri A., Murphy J. P., Cro L., Ferrero D., Tarella C., Baldini L., Dalla-Favera R. Ras oncogene mutation in multiple myeloma. J. Exp. Med. 1989; 170: 1715–25
   PubMed Web of Science ®Google Scholar